Showing posts with label CPNLQ. Show all posts
Showing posts with label CPNLQ. Show all posts

Wednesday, January 10, 2007

Stock Results: 1/10/07

Click the following link for a snapshot of today's performance of my watches. 1/10/07 Results

Surprise for me today was FICC which closed the day up 9.28% after being down 11 days in a row. I added FICC to the watch list after reading somewhat controversial stockfetcher forum post titled "Buy on Red". Adding the suggested columns, FICC had an RSI(2) = 0.0038 , %R -96.45 and Fast %K 2.50, took a look at the lbb ride on the chart. Interesting way to find the low riders. I should add, I could have also just screened for Fast %K<10 and then sort by RSI column, but the addition of the "11 days down" added another element. Running the screen intraday was also useful - came across RDYN which had also been down 11 days, it added 2.74% in trading today.

CPNLQ added almost 8% on volume of over 16 million vs. 6 million average. SKNN closed slightly up 0.80%. Yesterday's fail ISON performed well gaining almost 11% on average volume. Also fail RGBL took in 2.56% and Monday's fail LNX, took in 14.15%.

Forceswing candidate ZVUE still belonged to the bears, closed down 3.59% on very low volume. TERN pulled off a 3.00% gain on close to average volume.

Stock Watch 1/10/07

Fails! 'Nuff said.

TERN and ZVUE are my forceswing candidates.

Looking at TGEN CPWR NEXM CPNLQ SKNN FICC for some movement.

Monday, January 1, 2007

Stock Watch 1/3/07

I will continue to watch fails from last week ENCY ,CLWT and SIRI. I'll also be keeping my eyes on EPIX and LMRA for more positive gains.

Be sure to read any comments posted on this blog. You may find great insight in there. Muddy gave a heads up on CPNLQ and DCTH.

My forceswing candidate of the day is Targeted Genetics, TGEN which lost 8.83% in trading on Friday to close at $5.37 with no apparent news or rumours but looks poised for a reversal.

My curiousity of the day will have to be Northfield Labs, NFLD, whose recent drug disaster cost its shares to plunge over 70% since December. Northfield "reported a higher-than-expected death rate in a study for its blood substitute product PolyHeme". NFLD gained 6% in trading on Friday, to close up at $4.07. Although recent news has been pretty grim, it's had "2 straight up days inside". Worth a look?